Acorda Therapeutics Inc Vállalati érték
Mi az Acorda Therapeutics Inc Vállalati érték?
A Vállalati érték az Acorda Therapeutics Inc - $569.58M
Mi a Vállalati érték meghatározása?
A vállalati érték a vállalat teljes piaci értékének mértéke. A piaci kapitalizáció az adósság, a kisebbségi részesedés és a preferált részvények összege, a pénzeszközök és pénzeszköz-egyenértékek összege mínusz.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Vállalati érték a Health Care szektor a NASDAQ-on cégekben a Acorda Therapeutics Inc -hoz képest
Mit csinál Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
vállalati érték -hoz hasonló cégek Acorda Therapeutics Inc
- Heidelberger Druckmaschinen AG nak Vállalati érték $567.55M van
- IQE Plc nak Vállalati érték $568.18M van
- Artemis Gold nak Vállalati érték $568.28M van
- Royal Nickel nak Vállalati érték $568.77M van
- DCB Bank nak Vállalati érték $568.97M van
- Social Capital Hedosophia IV nak Vállalati érték $569.42M van
- Acorda Therapeutics Inc nak Vállalati érték $569.58M van
- DCB Bank nak Vállalati érték $569.78M van
- HeidelbergCement India nak Vállalati érték $569.90M van
- Wajax nak Vállalati érték $570.24M van
- Hollywood Bowl Plc nak Vállalati érték $571.02M van
- Digital Media Solutions nak Vállalati érték $571.18M van
- Jamna Auto Industries nak Vállalati érték $571.40M van